{"id":20460,"date":"2018-11-27T11:00:44","date_gmt":"2018-11-27T19:00:44","guid":{"rendered":"https:\/\/sop.washington.edu\/?p=20460"},"modified":"2025-12-04T11:36:59","modified_gmt":"2025-12-04T19:36:59","slug":"melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers","status":"publish","type":"post","link":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/","title":{"rendered":"Barker-Haliski\u2019s novel research looks at the under-studied problem of epilepsy in patients with Alzheimer\u2019s"},"content":{"rendered":"<figure id=\"attachment_20461\" aria-describedby=\"caption-attachment-20461\" style=\"width: 750px\" class=\"figure figure-caption wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-20461 size-full-content\" src=\"https:\/\/sop.washington.edu\/wp-content\/uploads\/Melissa_Leica-750x536.jpg\" alt=\"Melissa is a neuropharmacologist with a passion for understanding how drugs work in the body. Her research is supported by the UW Royalty Research Fund and the UWSOP Plein Fund Endowment. She and her team will present findings in December 2018 at the American Epilepsy Society meeting. Melissa works in collaboration with Suman Jayadev, associate professor of neurology at UW Medicine and the clinical core director of UW\u2019s Alzheimer\u2019s Disease Research Center.\" width=\"750\" height=\"536\" srcset=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica-750x536.jpg 750w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica-300x214.jpg 300w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica-768x549.jpg 768w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica-1024x732.jpg 1024w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica-375x268.jpg 375w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica-1140x814.jpg 1140w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica.jpg 1600w\" sizes=\"auto, 100vw\" \/><figcaption id=\"caption-attachment-20461\" class=\"wp-caption-text\">Melissa is a neuropharmacologist with a passion for understanding how drugs work in the body. Her research is supported by the UW Royalty Research Fund and the UWSOP Plein Fund Endowment. She works in collaboration with Suman Jayadev, associate professor of neurology at UW Medicine and the clinical core director of UW\u2019s Alzheimer\u2019s Disease Research Center. <\/figcaption><\/figure>\n<p>People with Alzheimer\u2019s disease can have up to an 87-fold increased risk of seizures. Patients with early-onset Alzheimer\u2019s have the highest risk for seizures, but even patients with \u00a0late onset Alzheimer\u2019s disease\u00a0 are at high risk.<\/p>\n<p>Despite the risks, little is known about how genes associated with Alzheimer\u2019s disease may affect a person\u2019s susceptibility to seizure across their lifespan. Even less is known about whether anticonvulsant drugs, which, historically, have been tested in young-adult animal models, are effective and well-tolerated in older populations, including those with Alzheimer\u2019s.<\/p>\n<p>Plein Center researcher <strong>Melissa Barker-Haliski<\/strong>hopes to answer this question using preclinical mouse models with Alzheimer\u2019s disease-associated genetic risk factors. Melissa is a neuropharmacologist with expertise in preclinical epilepsy models for anticonvulsant drug discovery. In collaboration with neurogeneticist and UW School of Medicine\u2019s Suman Jayadev, MD, Melissa and her team are investigating how seizures in these preclinical Alzheimer\u2019s disease models age-dependently affect disease trajectory and cognitive outcomes, as well as how anticonvulsant drugs affect seizure control in mice with these Alzheimer\u2019s disease-associated risk genes. Using a mouse model with a mutation in one of the most common early-onset Alzheimer\u2019s disease-associated risk genes (presenilin 2 [PSEN2]), they see how age affects the mice\u2019s susceptibility to seizures and whether those seizures age-dependently respond to available anticonvulsant medications.<\/p>\n<figure id=\"attachment_20462\" aria-describedby=\"caption-attachment-20462\" style=\"width: 300px\" class=\"figure figure-caption wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-20462\" src=\"https:\/\/sop.washington.edu\/wp-content\/uploads\/AL_Anticonvulsants-300x200.jpg\" alt=\"Melissa Barker-Haliski's findings suggest that if a patient is having seizures and has an Alzheimer\u2019s diagnosis, anticonvulsant therapies may effectively stop their seizures.\" width=\"300\" height=\"200\" srcset=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Anticonvulsants-300x200.jpg 300w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Anticonvulsants-768x512.jpg 768w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Anticonvulsants-1024x682.jpg 1024w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Anticonvulsants-375x250.jpg 375w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Anticonvulsants-750x500.jpg 750w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Anticonvulsants-1140x760.jpg 1140w, https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Anticonvulsants.jpg 1600w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><figcaption id=\"caption-attachment-20462\" class=\"wp-caption-text\">Melissa Barker-Haliski&#8217;s findings suggest that if a patient is having seizures and has an Alzheimer\u2019s diagnosis, anticonvulsant therapies may effectively stop their seizures. <\/figcaption><\/figure>\n<p>Melissa and her former undergraduate student, Megan Beckman (BS \u201918), will present this research at the Investigator\u2019s Workshop of the 2018 American Epilepsy Society Annual Meeting. Megan received one of 20 highly competitive Young Investigator\u2019s Award from the American Epilepsy Society to offset the costs to present this research work in December in New Orleans, LA. Melissa and Megan\u2019s research shows that many of the approved anticonvulsant medications reduce seizures in aged mice that carry the PSEN2 mutation.<\/p>\n<p>However, clinical studies in Alzheimer\u2019s disease patients are still needed. This work points to the potential positive impact anticonvulsants have on seizures in adults with Alzheimer\u2019s disease, and also may inform anticonvulsant medication usage in the general population of older adults. As older adults represent the fastest growing patient demographic with epilepsy diagnosis, preclinical and clinical studies of anticonvulsant drugs in these individuals is clearly warranted.<\/p>\n<blockquote>\n<p>\u201cAn implication of our findings is that patients with Alzheimer\u2019s disease could benefit if clinicians and neurologists examined their patients early in the disease course to determine if they are experiencing seizures.\u201d\u00a0\u2014Melissa Barker-Haliski, Research Assistant Professor, Pharmacy<\/p>\n<\/blockquote>\n<p>From a clinical perspective, the good news is Melissa\u2019s preclinical research aligns with the few clinical studies demonstrating that anticonvulsant drugs often work well in older adults, which may indicate their seizures can be controlled. People with Alzheimer\u2019s disease commonly present with seizures that are not the \u201cgrand mal\u201d type with generalized tonic-clonic convulsions. Seizures in older adults are often focal or what\u2019s historically called complex partial seizures\u2014which can seem like a mild stroke or may be called a \u201cspell\u201d\u2014and patients may be disoriented afterward. These seizures can be difficult to distinguish from common symptoms of Alzheimer\u2019s disease, making it challenging for clinicians, patients, and their families to recognize when and if seizures occur, further delaying anticonvulsant use.<\/p>\n<p>Some anticonvulsant drugs can even impair cognitive function in patients with epilepsy, so their use in people with Alzheimer\u2019s disease is a decision clinicians, patients, and their families should weigh carefully, given their promise to help. Melissa\u2019s work provides preclinical evidence that will inform the clinical studies of seizure control in patients with Alzheimer\u2019s disease. Her ongoing studies within the Plein center support growing recognition in the neurology community that seizures in patients with AD are a common, potentially detrimental, and often under-diagnosed component of the disease.<\/p>\n<h4>Are you interested in working with the top-rated faculty and\u00a0studying geriatric pharmacy with\u00a0preeminent student peers?<\/h4>\n<p>Click here for more information about the <a href=\"https:\/\/sop.washington.edu\/plein-center-in-geriatrics\/plein-certificate-in-geriatric-pharmacy\/\" target=\"_blank\" rel=\"noopener noreferrer\">Plein Geriatric Pharmacy Certificate<\/a>\u00a0or click these links to learn about the UW <a href=\"https:\/\/sop.washington.edu\/pharmd\/\" target=\"_blank\" rel=\"noopener noreferrer\">PharmD<\/a> program.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>People with Alzheimer\u2019s disease can have up to an 87-fold increased risk of seizures. Patients with early-onset Alzheimer\u2019s have the highest risk for seizures, but even patients with \u00a0late onset Alzheimer\u2019s disease\u00a0 are at high&#8230;<\/p>\n","protected":false},"author":3,"featured_media":20461,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[34,319],"tags":[],"class_list":["post-20460","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmacy-news","category-plein-center-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Barker-Haliski\u2019s novel research looks at the under-studied problem of epilepsy in patients with Alzheimer\u2019s - School of Pharmacy<\/title>\n<meta name=\"description\" content=\"People with Alzheimer\u2019s disease can have up to an 87-fold increased risk of seizures. Patients with early-onset Alzheimer\u2019s have the highest risk for\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Barker-Haliski\u2019s novel research looks at the under-studied problem of epilepsy in patients with Alzheimer\u2019s - School of Pharmacy\" \/>\n<meta property=\"og:description\" content=\"People with Alzheimer\u2019s disease can have up to an 87-fold increased risk of seizures. Patients with early-onset Alzheimer\u2019s have the highest risk for\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/\" \/>\n<meta property=\"og:site_name\" content=\"School of Pharmacy\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/UWSOP\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-27T19:00:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-04T19:36:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1143\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tim Wentzel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UW_Pharmacy\" \/>\n<meta name=\"twitter:site\" content=\"@UW_Pharmacy\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tim Wentzel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/\"},\"author\":{\"name\":\"Tim Wentzel\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/person\\\/21859bae0c32073fc2c8d833a054b09f\"},\"headline\":\"Barker-Haliski\u2019s novel research looks at the under-studied problem of epilepsy in patients with Alzheimer\u2019s\",\"datePublished\":\"2018-11-27T19:00:44+00:00\",\"dateModified\":\"2025-12-04T19:36:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/\"},\"wordCount\":772,\"publisher\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/Melissa_Leica.jpg\",\"articleSection\":[\"Pharmacy News\",\"Plein Center News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/\",\"name\":\"Barker-Haliski\u2019s novel research looks at the under-studied problem of epilepsy in patients with Alzheimer\u2019s - School of Pharmacy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/Melissa_Leica.jpg\",\"datePublished\":\"2018-11-27T19:00:44+00:00\",\"dateModified\":\"2025-12-04T19:36:59+00:00\",\"description\":\"People with Alzheimer\u2019s disease can have up to an 87-fold increased risk of seizures. Patients with early-onset Alzheimer\u2019s have the highest risk for\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/Melissa_Leica.jpg\",\"contentUrl\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/Melissa_Leica.jpg\",\"width\":1600,\"height\":1143,\"caption\":\"Melissa is a neuropharmacologist with a passion for understanding how drugs work in the body. Her research is supported by the UW Royalty Research Fund and the UWSOP Plein Fund Endowment. She and her team will present findings in December 2018 at the American Epilepsy Society meeting. Melissa works in collaboration with Suman Jayadev, associate professor of neurology at UW Medicine and the clinical core director of UW\u2019s Alzheimer\u2019s Disease Research Center.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Barker-Haliski\u2019s novel research looks at the under-studied problem of epilepsy in patients with Alzheimer\u2019s\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"name\":\"University of Washington School of Pharmacy\",\"description\":\"University of Washington\",\"publisher\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\"},\"alternateName\":\"UW School of Pharmacy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\",\"name\":\"University of Washington School of Pharmacy\",\"alternateName\":\"UW School of Pharmacy\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"contentUrl\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"width\":526,\"height\":527,\"caption\":\"University of Washington School of Pharmacy\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/www.facebook.com\\\/UWSOP\",\"https:\\\/\\\/x.com\\\/UW_Pharmacy\",\"https:\\\/\\\/www.instagram.com\\\/uw_pharmacy\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/UWPharmacySchool\",\"https:\\\/\\\/www.linkedin.com\\\/groups\\\/3820716\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/person\\\/21859bae0c32073fc2c8d833a054b09f\",\"name\":\"Tim Wentzel\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Barker-Haliski\u2019s novel research looks at the under-studied problem of epilepsy in patients with Alzheimer\u2019s - School of Pharmacy","description":"People with Alzheimer\u2019s disease can have up to an 87-fold increased risk of seizures. Patients with early-onset Alzheimer\u2019s have the highest risk for","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/","og_locale":"en_US","og_type":"article","og_title":"Barker-Haliski\u2019s novel research looks at the under-studied problem of epilepsy in patients with Alzheimer\u2019s - School of Pharmacy","og_description":"People with Alzheimer\u2019s disease can have up to an 87-fold increased risk of seizures. Patients with early-onset Alzheimer\u2019s have the highest risk for","og_url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/","og_site_name":"School of Pharmacy","article_publisher":"http:\/\/www.facebook.com\/UWSOP","article_published_time":"2018-11-27T19:00:44+00:00","article_modified_time":"2025-12-04T19:36:59+00:00","og_image":[{"width":1600,"height":1143,"url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica.jpg","type":"image\/jpeg"}],"author":"Tim Wentzel","twitter_card":"summary_large_image","twitter_creator":"@UW_Pharmacy","twitter_site":"@UW_Pharmacy","twitter_misc":{"Written by":"Tim Wentzel","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/#article","isPartOf":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/"},"author":{"name":"Tim Wentzel","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/person\/21859bae0c32073fc2c8d833a054b09f"},"headline":"Barker-Haliski\u2019s novel research looks at the under-studied problem of epilepsy in patients with Alzheimer\u2019s","datePublished":"2018-11-27T19:00:44+00:00","dateModified":"2025-12-04T19:36:59+00:00","mainEntityOfPage":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/"},"wordCount":772,"publisher":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/#primaryimage"},"thumbnailUrl":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica.jpg","articleSection":["Pharmacy News","Plein Center News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/","name":"Barker-Haliski\u2019s novel research looks at the under-studied problem of epilepsy in patients with Alzheimer\u2019s - School of Pharmacy","isPartOf":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/#primaryimage"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/#primaryimage"},"thumbnailUrl":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica.jpg","datePublished":"2018-11-27T19:00:44+00:00","dateModified":"2025-12-04T19:36:59+00:00","description":"People with Alzheimer\u2019s disease can have up to an 87-fold increased risk of seizures. Patients with early-onset Alzheimer\u2019s have the highest risk for","breadcrumb":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/#primaryimage","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica.jpg","contentUrl":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/Melissa_Leica.jpg","width":1600,"height":1143,"caption":"Melissa is a neuropharmacologist with a passion for understanding how drugs work in the body. Her research is supported by the UW Royalty Research Fund and the UWSOP Plein Fund Endowment. She and her team will present findings in December 2018 at the American Epilepsy Society meeting. Melissa works in collaboration with Suman Jayadev, associate professor of neurology at UW Medicine and the clinical core director of UW\u2019s Alzheimer\u2019s Disease Research Center."},{"@type":"BreadcrumbList","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/melissa-barker-haliskis-novel-research-looks-at-the-under-studied-problem-of-epilepsy-in-patients-with-alzheimers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/"},{"@type":"ListItem","position":2,"name":"Barker-Haliski\u2019s novel research looks at the under-studied problem of epilepsy in patients with Alzheimer\u2019s"}]},{"@type":"WebSite","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","name":"University of Washington School of Pharmacy","description":"University of Washington","publisher":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization"},"alternateName":"UW School of Pharmacy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization","name":"University of Washington School of Pharmacy","alternateName":"UW School of Pharmacy","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/","url":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","contentUrl":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","width":526,"height":527,"caption":"University of Washington School of Pharmacy"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/www.facebook.com\/UWSOP","https:\/\/x.com\/UW_Pharmacy","https:\/\/www.instagram.com\/uw_pharmacy\/","https:\/\/www.youtube.com\/user\/UWPharmacySchool","https:\/\/www.linkedin.com\/groups\/3820716"]},{"@type":"Person","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/person\/21859bae0c32073fc2c8d833a054b09f","name":"Tim Wentzel"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts\/20460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/comments?post=20460"}],"version-history":[{"count":0,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts\/20460\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/media\/20461"}],"wp:attachment":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/media?parent=20460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/categories?post=20460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/tags?post=20460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}